Drug uptake in CD1 mouse blood at 0.1 mCi, iv after 90 mins in presence of (S)-6-(4-Fluorophenoxy)-3-(piperidin-3-ylmethyl)-2-o-tolylquinazolin-4(3H)-one
Drug uptake in CD1 mouse heart at 0.1 mCi, iv after 90 mins in presence of (S)-6-(4-Fluorophenoxy)-3-(piperidin-3-ylmethyl)-2-o-tolylquinazolin-4(3H)-one
Drug uptake in CD1 mouse lung at 0.1 mCi, iv after 90 mins in presence of (S)-6-(4-Fluorophenoxy)-3-(piperidin-3-ylmethyl)-2-o-tolylquinazolin-4(3H)-one
Drug uptake in CD1 mouse adrenal at 0.1 mCi, iv after 90 mins in presence of (S)-6-(4-Fluorophenoxy)-3-(piperidin-3-ylmethyl)-2-o-tolylquinazolin-4(3H)-one
Drug uptake in CD1 mouse testis at 0.1 mCi, iv after 90 mins in presence of (S)-6-(4-Fluorophenoxy)-3-(piperidin-3-ylmethyl)-2-o-tolylquinazolin-4(3H)-one
Drug uptake in CD1 mouse muscle at 0.1 mCi, iv after 90 mins in presence of (S)-6-(4-Fluorophenoxy)-3-(piperidin-3-ylmethyl)-2-o-tolylquinazolin-4(3H)-one
Drug uptake in CD1 mouse liver at 0.1 mCi, iv after 90 mins in presence of (S)-6-(4-Fluorophenoxy)-3-(piperidin-3-ylmethyl)-2-o-tolylquinazolin-4(3H)-one